Search Results 71-80 of 3373 for ⚠구글 찌라시 ※프로그램:GTTVTT 구글유흥광고 구글웹툰광고 구글스포츠중계광고⚠
Dr. Drazkowski is continuing to participate in device trials for people with epilepsy and their impact will be maintained as part of his research program.
Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...
SUMMARY. The research program of Matthew A. Warner, M.D., studies patient blood management. Focus areas include clinical and translational research in the ...
About this study. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a ...
Laboratory testing from this study will be paired along with clinically significant data including medical history, bacterial infection types, inflammatory ...
Anticipated time on study treatment is 1 year or until disease progression or unacceptable toxicity occurs. Participation eligibility. Participant eligibility ...
The objective of this study is to obtain preliminary data to evaluate the accuracy of non-invasive blood pressure measurement in patients supported by ...
The purpose of this study is to use Ultrasound surface wave elastography to measure and compare the tissue thickness and elasticity in normal eyes and eyes with ...
Mayo Clinic researcher Andrea L. Cheville, M.D., creates and tests culturally informed digital interventions to improve cancer rehabilitation and pain ...
Joint motion and tendon excursion with respect to the subsynovial connective tissue ( SSCT ) strain will be combined to understand task specific motions related ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.